Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
Biochemical pharmacology - 84(2012), 6 vom: 15. Sept., Seite 821-830 |
| Beteiligte Personen: |
Li, Zhaosha [VerfasserIn] |
|---|
| Umfang: |
9 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1901333043 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1901333043 | ||
| 003 | DE-627 | ||
| 005 | 20230713100640.0 | ||
| 007 | tu | ||
| 008 | 120814s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120812_1 |
| 035 | |a (DE-627)OLC1901333043 | ||
| 035 | |a (DE-599)GBVOLC1901333043 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Li, Zhaosha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice |
| 264 | 1 | |c 2012 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Wang, Yanan |4 oth | |
| 700 | 1 | |a van der Sluis, Ronald J. |4 oth | |
| 700 | 1 | |a van der Hoorn, José W.A. |4 oth | |
| 700 | 1 | |a Princen, Hans M.G. |4 oth | |
| 700 | 1 | |a Van Eck, Miranda |4 oth | |
| 700 | 1 | |a Van Berkel, Theo J.C. |4 oth | |
| 700 | 1 | |a Rensen, Patrick C.N. |4 oth | |
| 700 | 1 | |a Hoekstra, Menno |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical pharmacology |d New York, NY : Elsevier, 1958 |g 84(2012), 6 vom: 15. Sept., Seite 821-830 |w (DE-627)12950355X |w (DE-600)208787-X |w (DE-576)014906775 |x 0006-2952 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2012 |g number:6 |g day:15 |g month:09 |g pages:821-830 |g extent:9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2012 |e 6 |b 15 |c 9 |h 821-830 |g 9 | ||